StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
Bellerophon Therapeutics stock opened at $0.06 on Friday. The firm has a market cap of $672,650.00, a P/E ratio of -0.07 and a beta of 0.71. The business has a fifty day moving average of $0.04 and a two-hundred day moving average of $0.05. Bellerophon Therapeutics has a twelve month low of $0.03 and a twelve month high of $0.10.
Bellerophon Therapeutics Company Profile
See Also
- Five stocks we like better than Bellerophon Therapeutics
- What Does a Stock Split Mean?
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Insider Trades May Not Tell You What You Think
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
